Equity Details
Price & Market Data
Price: $95.20
Daily Change: -$10.74 / 11.28%
Daily Range: $93.45 - $107.2
Market Cap: $4,334,154,752
Daily Volume: 1,306,328
Performance Metrics
1 Week: 17.93%
1 Month: 19.73%
3 Months: 2.49%
6 Months: -5.80%
1 Year: -13.31%
YTD: 15.14%
About BillionToOne, Inc. (BLLN)
Dive into the market stats for BillionToOne, Inc. (BLLN). Current price: 95.20, daily change: -$10.74 / 11.28%. Market cap: 4,334,154,752. All essential performance metrics are provided.
Company Details
Employees: 713
Sector: Health services
Industry: Medical/Nursing services
Country: United States
Details
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.